Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00061022
Status:
COMPLETED
Last Update Posted:
2010-11-15
First Post:
2003-05-20
Brief Title:
Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
SAINT Stroke - Acute Ischemic - NXY Treatment A Double Blind Randomized Placebo Controlled Parallel Group Multicenter Phase IIbIII Study to Assess the Efficacy and Safety of Intravenous NXY-059 in Acute Ischemic Stroke
Status:
COMPLETED
Status Verified Date:
2010-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will determine if NXY-059 will improve recovery from an acute stroke The study is designed to look at both overall recovery and recovery of motor function for example muscle strengthen and coordination
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| SAINT 2 | None | None | None |
| 007 | None | None | None |